Source: StreetInsider

Press Release: University of Bern : Molecular Partners Announces Research Collaboration with University of Bern to Develop MP0533, a Multispecific DARPin for the Treatment of AML

Research collaboration with leading acute myeloid leukemia (AML) experts, Professor Ochsenbein and Professor Riether from the Department of Medical Oncology, Inselspital, Bern University Hospital, Switzerland, to support advancement of drug development...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
5.0-10K
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100